January 2023

Global Cosmetics News

Two of Unilever’s production facilities have been awarded Lighthouse statues by the World Economic Forum. The award recognises the factories’ use of technology to enhance productivity and efficiency as well as their environmental credentials. The Tianjin site in China and the Indaiatuba plant in Brazil have been singled out as benchmarks and replicable models for manufacturers of all sizes, across different geographies and industries.

CosmeticsDesign-Asia

We speak to leading beauty and personal care brands to glean insights on three emerging markets ‘ Vietnam, the Middle East and Central Asia ‘ to see what 2023 has in store for the industry.

Path.org

Learn about the country’s first large-scale telehealth PrEP program and its innovative approaches to service delivery. In Vietnam, the COVID-19 Delta surge overwhelmed health care systems and severely restricted travel outside of the home. This prevented key populations at high risk for HIV—including men who have sex with men and transgender women—from accessing lifesaving HIV care, such as pre-exposure prophylaxis (PrEP).

The Malay Mail Online

Supermarket chain NTUC FairPrice has imposed a limit on the number of Panadol packs each customer can buy, while Panadol manufacturer Haleon said that it is producing “record quantities” of the medicine, given the increased demand for over-the-counter fever, cold and flu-related medicines in the past week.

The Malay Mail Online

A four-year-old child was taken to hospital after using a skin product supposed to treat rashes, the Health Sciences Authority (HSA) said today. Warning against its use, HSA said that the cream — known as Tao Ju Hui Yi Mei Li Shang Kou Hu Li Ruan Gao (淘聚汇益美丽伤口护理软膏) — had caused the child to suffer “serious adverse effects”.

The Malay Mail Online

India, one of the world’s biggest drug makers, is ready to step up exports of fever medicines to China as it reels from a spike in Covid-19 cases, the chairperson of an Indian drug export body today. China’s sudden easing of strict Covid-19 rules earlier this month triggered a surge in demand for fever medicines and virus test kits on the mainland, leading to shops imposing limits on how much customers can buy and drugmakers ramping up production.

News 18

It is time for India to capture the market of complex generics and biosimilar products after proving its capability in manufacturing Covid-19 vaccines, said a top pharma official in the Narendra Modi-led government.

CosmeticsDesign-Asia

Here we break down the hottest regulatory issues that will affect the cosmetics industry in APAC this year, with expert insights from leading industry insiders.